Search
Search Results
##search.searchResults.foundPlural##
-
EPIDEMIOLOGY OF MALARIA IN ENDEMIC AREAS
5305PDF: 2647HTML: 49578 -
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE
3612PDF: 1108HTML: 23338 -
ELEVATED P-SELECTIN IN SEVERE COVID-19: CONSIDERATIONS FOR THERAPEUTIC OPTIONS P-Selectine and COVID-19
1868PDF: 691HTML: 236 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1467PDF: 765Suppl. Files: 323Html: 136 -
IS HEMOGLOBIN E GENE WIDELY SPREAD IN THE STATE OF MADHYA PRADESH IN CENTRAL INDIA? EVIDENCE FROM FIVE TYPICAL FAMILIES
1390PDF: 877HTML: 7948Untitled: 200 -
EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT Sinopharm Vaccination in Iranian Patients with Hemoglobinopathies
1531PDF: 716HTML: 232 -
Fetal hemoglobin modifies the disease manifestation of severe Plasmodium falciparum malaria in adult patients with sickle cell anemia.
3239PDF: 914HTML: 759text and figure: 227 -
LATERAL SINUS THROMBOSIS IN OTOLOGY: A REVIEW
1587PDF: 937HTML: 4097Letter: 173 -
Ceftolozane-Tazobatam for febrile neutropenia treatment in hematologic malignancy patients colonized by multi-resistant Enterobacteriaceae: preliminary results from a prospective cohort study Ceftolozane-Tazobatam for febrile neutropenia
7844PDF: 721HTML: 216 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3688PDF: 1237HTML: 3894Untitled: 213Untitled: 259 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
2883PDF: 1360HTML: 3569Untitled: 192Untitled: 202Untitled: 177 -
SHORT HISTORY OF MALARIA AND ITS ERADICATION IN ITALY
4791PDF: 1898HTML: 11050Fig 1: 223Fig 2: 184Fig 3: 301Fig 4: 188Fig 5: 180Fig 6: 175Fig 7: 189Fig 8: 183 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1725PDF: 1163HTML: 246 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3268PDF: 1095HTML: 438 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1602PDF: 798HTML: 1232Figure 1: 172Figure 2: 188Figure 3: 183 -
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2069PDF: 1047HTML: 15650COVER LETTER: 190 -
CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE ELDERLY
2877PDF: 1099HTML: 3030 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4306PDF: 1373HTML: 2040 -
The COVID-19 in Omani children with chronic Hemato-oncology diseases COVID-19 in Omani children with chronic Hemato-oncology diseases
879PDF: 685HTML: 320 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7967PDF: 4138HTML: 7369 -
HAS HEMATOPOIETIC STEM CELL TRANSPLANTATION A ROLE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA? Acute Promyelocytic Leukemia and Hematopoietic Stem Cell Transplantation
1121PDF: 772HTML: 208







